Literature DB >> 24119843

Super-enhancers in the control of cell identity and disease.

Denes Hnisz1, Brian J Abraham, Tong Ihn Lee, Ashley Lau, Violaine Saint-André, Alla A Sigova, Heather A Hoke, Richard A Young.   

Abstract

Super-enhancers are large clusters of transcriptional enhancers that drive expression of genes that define cell identity. Improved understanding of the roles that super-enhancers play in biology would be afforded by knowing the constellation of factors that constitute these domains and by identifying super-enhancers across the spectrum of human cell types. We describe here the population of transcription factors, cofactors, chromatin regulators, and transcription apparatus occupying super-enhancers in embryonic stem cells and evidence that super-enhancers are highly transcribed. We produce a catalog of super-enhancers in a broad range of human cell types and find that super-enhancers associate with genes that control and define the biology of these cells. Interestingly, disease-associated variation is especially enriched in the super-enhancers of disease-relevant cell types. Furthermore, we find that cancer cells generate super-enhancers at oncogenes and other genes important in tumor pathogenesis. Thus, super-enhancers play key roles in human cell identity in health and in disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24119843      PMCID: PMC3841062          DOI: 10.1016/j.cell.2013.09.053

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  74 in total

1.  eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci.

Authors:  Kambiz Mousavi; Hossein Zare; Stefania Dell'orso; Lars Grontved; Gustavo Gutierrez-Cruz; Assia Derfoul; Gordon L Hager; Vittorio Sartorelli
Journal:  Mol Cell       Date:  2013-08-29       Impact factor: 17.970

Review 2.  The human Mi-2/NuRD complex and gene regulation.

Authors:  S A Denslow; P A Wade
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

Review 3.  Developmental biology. Enhancing pluripotency and lineage specification.

Authors:  Wei Xie; Bing Ren
Journal:  Science       Date:  2013-07-19       Impact factor: 47.728

Review 4.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

Review 5.  The enhanceosome.

Authors:  Daniel Panne
Journal:  Curr Opin Struct Biol       Date:  2008-02-21       Impact factor: 6.809

6.  Integration of external signaling pathways with the core transcriptional network in embryonic stem cells.

Authors:  Xi Chen; Han Xu; Ping Yuan; Fang Fang; Mikael Huss; Vinsensius B Vega; Eleanor Wong; Yuriy L Orlov; Weiwei Zhang; Jianming Jiang; Yuin-Han Loh; Hock Chuan Yeo; Zhen Xuan Yeo; Vipin Narang; Kunde Ramamoorthy Govindarajan; Bernard Leong; Atif Shahab; Yijun Ruan; Guillaume Bourque; Wing-Kin Sung; Neil D Clarke; Chia-Lin Wei; Huck-Hui Ng
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

Review 7.  Genetics and epigenetics of systemic lupus erythematosus.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

8.  Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.

Authors:  Keisuke Kaji; Jennifer Nichols; Brian Hendrich
Journal:  Development       Date:  2007-02-07       Impact factor: 6.868

9.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

10.  Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer.

Authors:  Reika Iwakawa; Masataka Takenaka; Takashi Kohno; Yoko Shimada; Yasushi Totoki; Tatsuhiro Shibata; Koji Tsuta; Ryo Nishikawa; Masayuki Noguchi; Aiko Sato-Otsubo; Seishi Ogawa; Jun Yokota
Journal:  Genes Chromosomes Cancer       Date:  2013-05-28       Impact factor: 5.006

View more
  1474 in total

1.  Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Authors:  Shiori Saito; Jiro Kikuchi; Daisuke Koyama; Shin Sato; Hiroo Koyama; Naoki Osada; Yoshiaki Kuroda; Koshi Akahane; Takeshi Inukai; Takashi Umehara; Yusuke Furukawa
Journal:  Clin Cancer Res       Date:  2018-12-05       Impact factor: 12.531

2.  Endothelial cell differentiation is encompassed by changes in long range interactions between inactive chromatin regions.

Authors:  Henri Niskanen; Irina Tuszynska; Rafal Zaborowski; Merja Heinäniemi; Seppo Ylä-Herttuala; Bartek Wilczynski; Minna U Kaikkonen
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

3.  Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Authors:  Michael R McKeown; M Ryan Corces; Matthew L Eaton; Chris Fiore; Emily Lee; Jeremy T Lopez; Mei Wei Chen; Darren Smith; Steven M Chan; Julie L Koenig; Kathryn Austgen; Matthew G Guenther; David A Orlando; Jakob Lovén; Christian C Fritz; Ravindra Majeti
Journal:  Cancer Discov       Date:  2017-07-20       Impact factor: 39.397

4.  BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.

Authors:  Qiming Duan; Sarah McMahon; Priti Anand; Hirsh Shah; Sean Thomas; Hazel T Salunga; Yu Huang; Rongli Zhang; Aarathi Sahadevan; Madeleine E Lemieux; Jonathan D Brown; Deepak Srivastava; James E Bradner; Timothy A McKinsey; Saptarsi M Haldar
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

5.  Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities.

Authors:  Timothy A Dinh; Ramja Sritharan; F Donelson Smith; Adam B Francisco; Rosanna K Ma; Rodica P Bunaciu; Matt Kanke; Charles G Danko; Andrew P Massa; John D Scott; Praveen Sethupathy
Journal:  Cell Rep       Date:  2020-04-14       Impact factor: 9.423

6.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor.

Authors:  Camilla L Christensen; Nicholas Kwiatkowski; Brian J Abraham; Julian Carretero; Fatima Al-Shahrour; Tinghu Zhang; Edmond Chipumuro; Grit S Herter-Sprie; Esra A Akbay; Abigail Altabef; Jianming Zhang; Takeshi Shimamura; Marzia Capelletti; Jakob B Reibel; Jillian D Cavanaugh; Peng Gao; Yan Liu; Signe R Michaelsen; Hans S Poulsen; Amir R Aref; David A Barbie; James E Bradner; Rani E George; Nathanael S Gray; Richard A Young; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

7.  Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.

Authors:  Surya Nagaraja; Nicholas A Vitanza; Pamelyn J Woo; Kathryn R Taylor; Fang Liu; Lei Zhang; Meng Li; Wei Meng; Anitha Ponnuswami; Wenchao Sun; Jie Ma; Esther Hulleman; Tomek Swigut; Joanna Wysocka; Yujie Tang; Michelle Monje
Journal:  Cancer Cell       Date:  2017-04-20       Impact factor: 31.743

8.  Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.

Authors:  Elizabeth Heyes; Luisa Schmidt; Gabriele Manhart; Thomas Eder; Ludovica Proietti; Florian Grebien
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

9.  Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Authors:  Chaochen Wang; Ji-Eun Lee; Binbin Lai; Todd S Macfarlan; Shiliyang Xu; Lenan Zhuang; Chengyu Liu; Weiqun Peng; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

10.  Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration.

Authors:  Jacquelyn O Russell; Sungjin Ko; Harvinder S Saggi; Sucha Singh; Minakshi Poddar; Donghun Shin; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2018-03-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.